Japanese encephalitis vaccine

Generic name
Japanese encephalitis vaccine
Brand name
ATC Code
J07BA02
Compare …

Japanese encephalitis vaccine

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Vaccination for Japanese encephalitis
  • Intramuscular
    • 2 months up to 3 years
      [1]
      • 0.25 ml/dose 2 vaccinations, as follows:. First vaccination: Day 0
        Second vaccination: Day 28.

      • Alternative administration: In exceptional cases, the vaccine can also be administered subcutaneously to patients with thrombocytopenia or blood clotting disorders, given that bleeding can occur after intramuscular injection. Subcutaneous administration could result in suboptimal response to the vaccine

    • 3 years up to 18 years
      [1]
      • 0.5 ml/dose 2 vaccinations, as follows:. First vaccination: Day 0
        Second vaccination: Day 28.

      • Alternative administration: In exceptional cases, the vaccine can also be administered subcutaneously to patients with thrombocytopenia or blood clotting disorders, given that bleeding can occur after intramuscular injection. Subcutaneous administration could result in suboptimal response to the vaccine

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects in children

In children up to 3 years of age very often: fever (about 29%), flu-like symptoms, diarrhea, irritability.

Other side effects: Lymphadenopathy, Decreased appetite, Headache, Cough, nausea, vomiting, abdominal pain, rash, myalgia, fatigue. Increase in liver enzyme levels.
At the injection site: redness, swelling, pain, tenderness, itching, hardening.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

VIRAL VACCINES

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Encephalitis vaccines
J07BA01
Influenza vaccines
J07BB02
Hepatitis vaccines
J07BC20
J07BC02
J07BC01
Measles vaccines
J07BD52
Poliomyelitis vaccines
J07BF03
Rabies vaccines
J07BG01
Rota virus diarrhea vaccines
J07BH01
Varicella zoster vaccines
J07BK01
Yellow fever vaccines
J07BL01
Papillomavirus vaccines
J07BM03
J07BM02
Other viral vaccines
J07BX04

Reference

  1. Valneva Austria GmbH, SmPC Ixiaro (EU/1/08/501/001-002) 31-3-2014

Changes

Therapeutic Drug Monitoring


Overdose